Maternal anxiety about first trimester nuchal translucency screening and impact of positive screening results

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 12, 2007, Pages 1437-1441

  Chueh, Ho Yen ^a   Cheng, Po Jen ^a,b   Shaw, Sheng Wen ^a   Lin, Cheng Tao ^a   Hsu, Jenn Jeih ^a   Hsieh, T'Sang T'Ang ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Anxiety; Down syndrome; Nuchal translucency; Prenatal screening; Psychological impact

Indexed keywords

ANXIETY; ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN EXPERIMENT; MATERNAL BEHAVIOR; NUCHAL TRANSLUCENCY MEASUREMENT; PRIORITY JOURNAL;

ANXIETY; CASE-CONTROL STUDIES; DOWN SYNDROME; FEMALE; HUMANS; MOTHERS; NECK; NUCHAL TRANSLUCENCY MEASUREMENT; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; TAIWAN;

EID: 36248943188     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340701622724     Document Type: Article

References (20)

1. Chasen ST, Sharma G, Kalish RB, Chervenak FA. Firsttrimester screening for aneuploidy with fetal nuchal translucency in a United States population. Ultrasound Obstet Gynecol. 2003;22:149-51.
2. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol. 2005;25:221-6.
3. Valinen Y, Rapakko K, Kokkonen H, Laitinen P, Tekay A, Ahola T, et al. Clinical first-trimester routine screening for Down syndrome in singleton pregnancies in northern Finland. Am J Obstet Gynecol. 2007;196:278.e1-5.
4. Weinans MJ, Kooij L, Muller MA, Bilardo KM, Van Lith JM, Tymstra T. A comparison of the impact of screen-positive results obtained from ultrasound and biochemical screening for Down syndrome in the first trimester: a pilot study. Prenat Diagn. 2004;24:347-51.
5. Kaiser AS, Ferris LE, Pastuszak AL, Llewellyn-Thomas H, Johnson JA, Conacher S, et al. The effects of prenatal group genetic counselling on knowledge, anxiety and decisional conflict: issues for nuchal translucency screening. J Obstet Gynaecol. 2002;22:246-55.
6. Kaiser AS, Ferris LE, Katz R, Pastuszak A, Llewellyn-Thomas H, Johnson JA, et al. Psychological responses to prenatal NTS counseling and the uptake of invasive testing in women of advanced maternal age. Patient Educ Couns. 2004;54:45-53.
7. Chan LW, Chau MC, Leung TY, Fung TY, Leung TN, Lau TK. Expectation and knowledge of women undergoing first-trimester combined screening for Down syndrome in a Chinese population. Prenat Diagn. 2005;25:1248-52.
8. Muller MA, Bleker OP, Bonsel GJ, Bilardo CM. Nuchal translucency screening and anxiety levels in pregnancy and puerperium. Ultrasound Obstet Gynecol. 2006;27:357-61.
9. Cheng PJ, Chang SD, Shaw SW, Soong YK. Nuchal translucency thickness in fetuses with chromosomal translocation at 11-12 weeks of gestation. Obstet Gynecol. 2005;105:1058-62.
10. Cheng PJ, Shaw SW, Soong YK. Association of fetal choroid plexus cysts with trisomy 18 in a population previously screened by nuchal translucency thickness measurement. J Soc Gynecol Invest. 2006;13:280-4.
11. Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol. 2004;191:45-67.
12. Loo R. The State-Trait Anxiety Inventory A-Trait Scale: dimensions and their generalization. J Pers Assess. 1979;43:50-3.
13. Abuelo DN, Hopmann MR, Barsel-Bowers G, Goldstein A. Anxiety in women with low maternal serum alpha-fetoprotein screening results. Prenat Diagn. 1991;11:381-5.
14. Marteau TM, Cook R, Kidd J, Michie S, Johnston M, Slack J, et al. The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diagn. 1992;12:205-14.
15. Georgsson OS, Saltvedt S, Grunewald C, Waldenstrom U. Does fetal screening affect women's worries about the health of their baby? A randomized controlled trial of ultrasound screening for Down's syndrome versus routine ultrasound screening. Acta Obstet Gynecol Scand. 2004;83:634-40.
16. Goel V, Glazier R, Summers A, Holzapfel S. Psychological outcomes following maternal serum screening: a cohort study. CMAJ. 1998;159:651-6.
17. Rausch DN, Lambert-Messerlian GM, Canick JA. Participation in maternal serum screening following screen positive results in a previous pregnancy. J Med Screen. 2000;7:4-6.
18. Weinans MJ, Kooij L, Muller MA, Bilardo KM, Van Lith JM, Tymstra T. A comparison of the impact of screen-positive results obtained from ultrasound and biochemical screening for Down syndrome in the first trimester: a pilot study. Prenat Diagn. 2004;24:347-51.
19. Muller MA, Bleker OP, Bonsel GJ, Bilardo CM. Women's opinions on the offer and use of nuchal translucency screening for Down syndrome. Prenat Diagn. 2006;26:105-11.
20. Dipietro JA, Irizarry RA, Costigan KA, Gurewitsch ED. The psychophysiology of the maternal-fetal relationship. Psychophysiology. 2004;41:510-20.